Literature DB >> 21292796

Computer-assisted system for diagnosis of Alzheimer disease using data base- independent estimation and fluorodeoxyglucose- positron-emission tomography and 3D-stereotactic surface projection.

T Uemura1, K Ishii, N Miyamoto, T Yoshikawa.   

Abstract

BACKGROUND AND
PURPOSE: Recently, voxel-based statistical parametric images have been developed as additional diagnostic tools for AD. However these methods require the generation of a data base of healthy brain images. The purpose of this study was to produce and evaluate an automatic method using a data base-independent estimation system for the diagnosis of mild AD.
MATERIALS AND METHODS: We retrospectively selected 66 subjects, including 33 patients with early AD and 33 age-matched healthy volunteers. Individual brain metabolic images were obtained by using FDG-PET. These were transformed by using 3D-SSP. We then produced CADDIES, which compares the parietal and sensorimotor metabolic counts by using t tests. If parietal metabolism was significantly lower than the sensorimotor metabolism, the subject was automatically diagnosed as having AD. The FDG-PET images were also analyzed by using a previous automatic diagnosis system (CAAD) that is dependent on the construction of a "normal data base" of healthy brain images. Diagnostic performance was compared between the 2 methods.
RESULTS: The CADDIES demonstrated a sensitivity of 88%, specificity of 79%, and accuracy of 85%, while the CAAD system demonstrated a sensitivity of 70%, specificity of 94%, and accuracy of 82%. The area under the ROC curve of CADDIES was 0.964. The areas under ROC curves of the CAAD method in the parietal and posterior cingulate gyri were 0.843 and 0.939, respectively.
CONCLUSIONS: The CADDIES method demonstrated a diagnostic accuracy similar to that of the CAAD system. Our results indicate that this method can be applied to the detection of patients with early AD in routine clinical examinations, with the benefit of not requiring the generation of a normal data base.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292796      PMCID: PMC8013077          DOI: 10.3174/ajnr.A2342

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis.

Authors:  Wei-Ping Chen; Miharu Samuraki; Daisuke Yanase; Keisuke Shima; Nozomi Takeda; Kenjiro Ono; Mitsuhiro Yoshita; Shintaro Nishimura; Masahito Yamada; Ichiro Matsunari
Journal:  Nucl Med Commun       Date:  2008-03       Impact factor: 1.690

2.  Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.

Authors:  K Ishii; M Sasaki; H Kitagaki; S Yamaji; S Sakamoto; K Matsuda; E Mori
Journal:  J Nucl Med       Date:  1997-06       Impact factor: 10.057

3.  Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.

Authors:  Atsushi K Kono; Kazunari Ishii; Keitaro Sofue; Naokazu Miyamoto; Setsu Sakamoto; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-22       Impact factor: 9.236

Review 4.  Clinical application of positron emission tomography for diagnosis of dementia.

Authors:  Kazunari Ishii
Journal:  Ann Nucl Med       Date:  2002-12       Impact factor: 2.668

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.

Authors:  Kazunari Ishii; Atsushi K Kono; Hiroki Sasaki; Naokazu Miyamoto; Tetsuya Fukuda; Setsu Sakamoto; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-10       Impact factor: 9.236

7.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

Authors:  S Minoshima; K A Frey; R A Koeppe; N L Foster; D E Kuhl
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

Review 8.  PET studies in dementia.

Authors:  Karl Herholz
Journal:  Ann Nucl Med       Date:  2003-04       Impact factor: 2.668

9.  Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.

Authors:  S Minoshima; K A Frey; N L Foster; D E Kuhl
Journal:  J Comput Assist Tomogr       Date:  1995 Jul-Aug       Impact factor: 1.826

10.  Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18.

Authors:  Igor Yakushev; Christian Landvogt; Hans-Georg Buchholz; Andreas Fellgiebel; Alexander Hammers; Armin Scheurich; Irene Schmidtmann; Alexander Gerhard; Mathias Schreckenberger; Peter Bartenstein
Journal:  Psychiatry Res       Date:  2008-10-19       Impact factor: 3.222

View more
  2 in total

1.  Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.

Authors:  S Shokouhi; D Claassen; Wr Riddle
Journal:  J Alzheimers Dis Parkinsonism       Date:  2014-04

2.  Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia.

Authors:  Jahae Kim; Sang-Geon Cho; Minchul Song; Sae-Ryung Kang; Seong Young Kwon; Kang-Ho Choi; Seong-Min Choi; Byeong-Chae Kim; Ho-Chun Song
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.